United States · How much has Sprout Pharmaceuticals raised?
Sprout Pharmaceuticals has raised $99M across 5 rounds since 2012.
2013201420152016201720182019
$20MVenture$4.8MVenture$4.3MVenture$50MVenture$20MRound
United States · Funded startup
Who invested in Sprout Pharmaceuticals
5 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Sprout Pharmaceuticals and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$99Mraised across 5 rounds since 2012, from 5 sources
$20MVenture$50MVenture$20MRound
- Latest round
- Round, $20MSept 2019
- Biggest round
- $50MVenture · Jun 2015
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $20M Jul 2012
- Biggest round
- $50M Venture · Jun 2015
- Usual gap between rounds
- 13 months the median of 4
The rounds
- Sept 2019
- Jun 2015Venture$50M
No investor was named in the report.
From a historical funding recordSEC filing: $50M sold, first sale May 2015
- Jul 2014Venture$4.3M
No investor was named in the report.
From a historical funding recordSEC filing: $4.3M sold, first sale Jun 2014
- Jun 2013Venture$4.8M
No investor was named in the report.
Reported by sec.govSEC filing: $4.8M sold, first sale Jun 2013
- Jul 2012Venture$20M
No investor was named in the report.
Reported by fiercebiotech.comSEC filing: $20M sold, first sale Jun 2012
Funding filed with regulators
Sprout Pharmaceuticals filed 5 raises, $89M in all. Filings say how much was sold and to how many investors; they never name the investors.
- May 2015$50MSEC Form D
- Jun 2014$4.3MSEC Form D
- Jun 2013$10.0MSEC Form D
- Jun 2012$20MSEC Form D
- Mar 2012$5.0MSEC Form D
Founders and team
From the SEC filings it signed: 8 on the team.
- Cynthia WhiteheadDirector, President and Chief Executive Officeri
- Anne S. TomalinVice President, Global Regulatory Affairsi
- James S. PrudenVice President, Manufacturingi
- Josephine S. TorrenteExecutive Vice President, Corporate and Regulatory Affairsi
- Rich S. FrancoExecutive Vice President, Strategyi
- Matthew S. PetzoldChief Financial Officer and Treasureri
- Douglas S. EckertDirector, Secretaryi
- Robert S. WhiteheadDirector, Executive Directori
On the board, as filediAnthony S. WildBraxton Robert GoodrichMichael Robert FordRichard Robert DeSchutterTrygve Robert MikkelsenW. Robert Dahl
The exit
ExitBuyerPriceWhen
AcquiredValeant Pharmaceuticals International$1.0BAug 2015
From historical deal records. Wrong? Tell us.
Quick answers about Sprout Pharmaceuticals
When did Sprout Pharmaceuticals last raise?
Sprout Pharmaceuticals's most recent round was an Undisclosed round of $20M in Sept 2019.
What was Sprout Pharmaceuticals's biggest round?
Sprout Pharmaceuticals's largest round on record is $50M (Venture), in Jun 2015.
What stage is Sprout Pharmaceuticals at?
Sprout Pharmaceuticals's latest named round is an Undisclosed round, in Sept 2019.
Where is Sprout Pharmaceuticals based?
Sprout Pharmaceuticals is based in the United States.
Companies like Sprout Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.